Novel Agent for AD Agitation Continues to Show Promise ...Middle East

News by : (Medscape) -
Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Agent for AD Agitation Continues to Show Promise )

Also on site :

Most Viewed News
جديد الاخبار